MedPath

Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence

Not Applicable
Completed
Conditions
Bacterial Vaginosis
Registration Number
NCT00542074
Lead Sponsor
University of Washington
Brief Summary

Randomized controlled trial (RCT) to evaluate the effectiveness of applying Purell® (62% ethyl alcohol in emollient gel) to the penis of male partners of women diagnosed with BV for preventing BV recurrence after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
223
Inclusion Criteria

Not provided

Exclusion Criteria
  • Either male or female partner not recruited within 24 hours of the other

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
bacterial vaginosis by Nugent's scoreup to 2 months following treatment
Secondary Outcome Measures
NameTimeMethod
presence of lactobacillus by culture2 months following treatment

Trial Locations

Locations (1)

Nairobi City Council STI referral clinic (Special Treatment Clinic)

🇰🇪

Nairobi, Kenya

Nairobi City Council STI referral clinic (Special Treatment Clinic)
🇰🇪Nairobi, Kenya

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.